ARE three-lens brief
Evidence-based stock research on ARE. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Moved +2.20% yesterday. · Trading at 13% of its 52-week range — deep in the lower band.
- Moved +2.20% yesterday.
- Trading at 13% of its 52-week range — deep in the lower band.
- Underperforming SPY by 12.9pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $57.86 — 22% above current (14 analysts).
ARE closed at $47.40 (+2.20%) as of 2026-04-25. Market cap: $8.21B. Positives: moved +2.20% yesterday.; analyst mean target $57.86 — 22% above current (14 analysts).. Concerns: trading at 13% of its 52-week range — deep in the lower band.; underperforming SPY by 12.9pp over 30 days.. Last quarter: Revenue $754.41M, net income -$1.08B, free cash flow $1.35B.
Why three lenses on ARE, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AREacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ARE" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ARE brief"></iframe>